The below Parliamentary question was asked by Seema Malhotra on 2015-10-26.
To ask Mr Chancellor of the Exchequer, if he will estimate the potential additional tax revenues accruing to the public purse of paying 18 to 21 year olds the national living wage.
Damian Hinds
The information requested is not available.
The below Parliamentary question was asked by David Burrowes on 2015-10-26.
To ask the Secretary of State for Health, whether a representative of HM Prisons Service sits on the Mental Health Task Force.
Alistair Burt
The Mental Health Task Force does not include a representative of HM Prison Service amongst its membership.
The below Parliamentary question was asked by Natalie McGarry on 2015-10-26.
To ask the Secretary of State for Work and Pensions, how many notifications of claimant non-compliance have been received by decision makers in his Department relating to claims for employment and support allowance; and what proportion of those notifications have resulted in sanctions.
Priti Patel
The information as requested is not readily available and could only be provided at disproportionate cost.
The information that is available, on the number of sanction referrals and adverse sanction decisions, in respect of Employment and Support Allowance (ESA) and Jobseeker’s Allowance (JSA), is published and available at:
https://stat-xplore.dwp.gov.uk/:
Guidance on how to extract the information required can be found at:
https://sw.stat-xplore.dwp.gov.uk/webapi/online-help/Getting-Started—SuperWEB2.html
“
The below Parliamentary question was asked by Gareth Thomas on 2015-10-26.
To ask the Secretary of State for Defence, what steps he is taking to promote the use of credit unions in the work of his Department; and if he will make a statement.
Mark Lancaster
I refer the hon. Member to the answer given to him by my hon. Friend the Economic Secretary to the Treasury (Harriet Baldwin) on the 2 November 2015 to Question 13524.
The below Parliamentary question was asked by Norman Lamb on 2015-10-26.
To ask the Secretary of State for Health, when he expects his Department to publish its response to its consultation for people with learning disabilities, autism and mental health conditions, entitled No voice unheard, no right ignored.
Alistair Burt
The Department is currently preparing its response to the consultation ‘No voice unheard, no right ignored’. The consultation sought views on a range of issues, including possible legislation to strengthen the rights of people with learning disabilities, autism and mental health conditions. It expects to publish the response during the autumn.
The below Parliamentary question was asked by Antoinette Sandbach on 2015-10-26.
To ask Mr Chancellor of the Exchequer, if he will bring forward proposals to prevent private pharmacies from being able to reclaim the 20 per cent VAT they pay suppliers for medicines.
Mr David Gauke
In common with other businesses, private pharmacies are entitled to reclaim the VAT paid on costs connected with their taxable activity.
The below Parliamentary question was asked by Andrew Rosindell on 2015-10-26.
To ask Mr Chancellor of the Exchequer, what steps he is taking to ensure that employers use the correct pension classification code and pay their due amount as contributions.
Mr David Gauke
HM Revenue and Customs (HMRC) publishes detailed guidance for employers on the GOV.UK website about National Insurance Contributions category letters.
https://www.gov.uk/national-insurance-rates-letters
All employers with an occupational pension scheme receive a reference number (Employer Contracted-Out Number) from HMRC. This allows the employer to use specific category letters which indicate that they are paying contracted-out contributions when they make their Real Time Information returns to HMRC. There are also automated checks in place to identify if an incorrect category letters has been used and these are then followed-up with the employer.
“
The below Parliamentary question was asked by Tom Brake on 2015-10-26.
To ask the Secretary of State for Health, what assessment he made of the potential effect of his plans for improving patient safety and zero harm on reducing the cost of clinical negligence before taking forward proposals for a fixed-costs regime in clinical negligence.
Ben Gummer
We are planning to consult on the introduction of the fixed cost regime for clinical negligence claims where the damages awarded to claimants are less than £250,000. This forms part of our over-arching objective to minimise adverse incidents and provide an efficient, cost-effective approach to litigation. In doing this we are seeking to improve patient care by reducing the incidence of clinical negligence, improve customer care by ensuring the National Health Service is responsive to users; and ensure there is an appropriate and cost effective legal process in place for claimants and defendants.
In advance of this work a pre-consultation exercise was undertaken with a wide range of bodies representing the views of patients, lawyers, bar organisations, professional bodies, NHS organisations, private healthcare providers and Welsh interests. Issues raised by these organisations included: access to justice, impact of the Legal Aid, Sentencing and Punishment of Offenders Act 2012; patient safety; and the avoidance of unnecessary costs in clinical negligence cases. These views will be rehearsed in the proposed consultation document and will inform decisions that are made following the consultation exercise. Respondents will have the opportunity to provide comments on the proposals, which we have been developing with the Civil Procedure Rules Committee.
The below Parliamentary question was asked by Louise Haigh on 2015-10-26.
To ask the Secretary of State for the Home Department, how many (a) forced and (b) voluntary former unaccompanied asylum-seeking children returnees were not accepted by Afghanistan and sent back to the UK in (a) 2010, (b) 2011, (c) 2012, (d) 2013, (e) 2014 and (f) 2015 to date.
James Brokenshire
The information that has been requested is not recorded by the Department.
The below Parliamentary question was asked by Laurence Robertson on 2015-10-26.
To ask the Secretary of State for Health, what recent assessment he has made of the effectiveness of the (a) Bendamustine and (b) Ibrutinib drugs in treating cancer; and if he will make a statement.
George Freeman
The National Institute for Health and Care Excellence (NICE) is the independent body which makes decisions on the clinical and cost effectiveness of products based on a thorough assessment of the best available evidence and in consultation with stakeholders. National Health Service commissioners are required to fund drugs and treatments recommended by NICE technology appraisals.
Bendamustine (Levact) is recommended by NICE as a possible treatment for some people with chronic lymphocytic leukaemia of Binet stage B or C.
NICE is currently appraising ibrutinib (Imbruvica) for the treatment of (i) chronic lymphocytic leukaemia (NICE’s final guidance is expected in June 2016) and (ii) mantle cell, relapsed, refractory lymphoma (NICE’s final guidance is expected in December 2016).